Research Progress on Intelligent Drug Delivery Systems in Chronic Inflammatory Diseases

Authors

  • Chengxin Zhang Pharmaceutical College, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China Author
  • Qingru Sun Pharmaceutical College, Zhejiang Chinese Medical University, 310053 Hangzhou, Zhejiang, China Author
  • Xier Xu College of Agriculture & Biotechnology, Zhejiang University, 310058 Hangzhou, Zhejiang, China Author

DOI:

https://doi.org/10.62767/jecacm701.7821

Keywords:

chronic inflammatory diseases, intelligent drug delivery system, personalized treatment, response, carrier

Abstract

Chronic inflammatory diseases are a serious challenge in global public health, and traditional routes of administration have many limitations due to their lack of precision and controllability. As an innovative drug delivery strategy, intelligent drug delivery system (IDDS) has attracted widespread attention. This dosage form can respond to internal and external stimuli (such as changes in pH, temperature, enzyme activity, light sensitivity, and magnetic sensitivity), thereby achieving precise and selective release of drugs. This article systematically reviews electronic databases (PubMed, Web of Science, ScienceDirect, and CNKI) to find studies published between 2012 and 2025, focusing on the core characteristics of the chronic inflammatory microenvironment and its guiding significance in the design of IDDS. This article highlights the construction strategies and response mechanisms of various IDSS, including nanoparticles, liposomes, hydrogels, cell membrane-based biomimetic systems, and prodrug strategies, as well as their application progress in chronic inflammatory diseases such as inflammatory bowel disease, arthritis, skin diseases, respiratory diseases, liver and kidney diseases, ocular diseases, and cardiovascular diseases. The article also explores the mechanisms and advantages of IDDS in targeted delivery, controlled release, and various responsive systems (such as pH, enzyme, magnetic, thermal, light, and ultrasound), and investigates the benefits, challenges, and future application prospects of the latest research and application advances in the treatment of chronic inflammatory diseases. These IDDS has opened up new paths for enhancing therapeutic efficacy, reducing toxic side effects, and enabling personalized treatment in chronic inflammatory diseases, offering new hope for future medical treatment.

References

Feng X, Xie Q, Xu H, et al. Yeast Microcapsule Mediated Natural Products Delivery for Treating Ulcerative Colitis through Anti-Inflammatory and Regulation of Macrophage Polarization. ACS Applied Materials & Interfaces 2022; 14(27): 31085-31098.

Deng Z, Liu S. Inflammation-responsive delivery systems for the treatment of chronic inflammatory diseases. Drug Delivery and Translational Research 2021; 11(4): 1475-1497.

Schett G, Neurath MF. Resolution of chronic inflammatory disease: universal and tissue-specific concepts. Nature Communications 2018; 9(1): 3261.

Crielaard BJ, Lammers T, Schiffelers RM, et al. Drug targeting systems for inflammatory disease: one for all, all for one. Journal of Controlled Release: Official Journal of the Controlled Release Society 2012; 161(2): 225-234.

Netea MG, Balkwill F, Chonchol M, et al. A guiding map for inflammation. Nature Immunology 2017, 18(8): 826-831.

Ding H, Tan P, Fu S, et al. Preparation and application of pH-responsive drug delivery systems. Journal of Controlled Release: Official Journal of the Controlled Release Society 2022; 348: 206-238.

Liu L, Feng X, Zhao J, et al. DNA logic circuit coupled with enzymatic amplification for signal-enhanced, AND-gated imaging of inflammation-associated mRNAs. Nano Today 2025; 62: 102700.

Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiological Reviews 2014; 94(3): 909-950.

Giles DA, Ramkhelawon B, Donelan EM, et al. Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice. Molecular Metabolism 2016; 5(11): 1121-1130.

Lan J, Zhao J, Zhang X. Advances in studies on intelligent drug delivery system. Drugs & Clinic 2012; 27(05): 488-492.

Feng L, Xie R, Wang C, et al. Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation. ACS Nano 2018; 12(11): 11000-11012.

Mitchell MJ, Billingsley MM, Haley RM, et al. Engineering precision nanoparticles for drug delivery. Nature Reviews Drug Discovery 2021; 20(2): 101-124.

Hu D, Li R, Li Y, et al. Inflammation-Targeted Nanomedicines Alleviate Oxidative Stress and Reprogram Macrophages Polarization for Myocardial Infarction Treatment. Advanced Science (Weinheim, Baden-Wurttemberg, Germany), 2024; 11(21): e2308910.

Li X, Liu X, Liu X. Self-assembly of colloidal inorganic nanocrystals: nanoscale forces, emergent properties and applications. Chemical Society Reviews 2021; 50(3): 2074-2101.

Zhang X, Wu J, Lin D. Construction of Intelligent Nano-Drug Delivery System for Targeting Extranodal Nasal Natural Killer/Thymus Dependent Lymphocyte. Journal of Biomedical Nanotechnology 2021; 17(3): 487-500.

Wang S, Copeland L. Effect of acid hydrolysis on starch structure and functionality: a review. Critical Reviews in Food Science and Nutrition 2015; 55(8): 1081-1097.

Malamatari M, Taylor KMG, Malamataris S, et al. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discovery Today 2018; 23(3): 534-547.

Sotniczuk A, Heise S, Topolski K, et al. Chitosan/bioactive glass coatings as a protective layer against corrosion of nanocrystalline titanium under simulated inflammation. Materials Letters 2020; 264: 127284.

Lu Y, Lv Y, Li T. Hybrid drug nanocrystals. Advanced Drug Delivery Reviews 2019; 143: 115-133.

Wang M, Cha R, Hao W, et al. Nanocrystalline Cellulose Modulates Dysregulated Intestinal Barriers in Ulcerative Colitis. ACS Nano 2023; 17(19): 18965-18978.

Zainal-Abidin MH, Hayyan M, Ngoh GC, et al. Emerging frontiers of deep eutectic solvents in drug discovery and drug delivery system. Journal of Controlled Release: Official Journal of the Controlled Release Society 2019; 316: 168-195.

Serrano DR, Walsh D, O’Connell P, et al. Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V 2018; 124: 13-27.

Thipparaboina R, Thumuri D, Chavan R, et al. Fast dissolving drug-drug eutectics with improved compressibility and synergistic effects. European Journal of Pharmaceutical Sciences 2017; 104: 82-89.

Amadi EV, Venkataraman A, Papadopoulos C. Nanoscale self-assembly: concepts, applications and challenges. Nanotechnology 2022, 33(13).

Lin H, Yang Y, Li Y, et al. Bioenhanced degradation of toluene by layer-by-layer self-assembled silica-based bio-microcapsules. Frontiers in Microbiology 2023; 14: 1122966.

Shen L, Zhang Y, Feng J, et al. Microencapsulation of Ionic Liquid by Interfacial Self-Assembly of Metal-Phenolic Network for Efficient Gastric Absorption of Oral Drug Delivery. ACS Applied Materials & Interfaces 2022; 14(40): 45229-45239.

Liu J, Lan Y, Yu Z, et al. Cucurbit[n]uril-Based Microcapsules Self-Assembled within Microfluidic Droplets: A Versatile Approach for Supramolecular Architectures and Materials. Accounts of Chemical Research 2017; 50(2): 208-217.

Cini N, Calisir F. Layer-by-layer self-assembled emerging systems for nanosized drug delivery. Nanomedicine (London, England) 2022; 17(25): 1961-1980.

Kurz H, Hils C, Timm J, et al. Self-Assembled Fluorescent Block Copolymer Micelles with Responsive Emission. Angewandte Chemie (International Ed. in English) 2022; 61(15): e202117570.

Wang Y, Jiang W, Jiang Y, et al. Self-assembled nano-micelles of lactoferrin peptides: Structure, physicochemical properties, and application for encapsulating and delivering curcumin. Food Chemistry 2022; 387: 132790.

Zhao Y, Song L, Li M, et al. Injectable CNPs/DMP1-loaded self-assembly hydrogel regulating inflammation of dental pulp stem cells for dentin regeneration. Materials Today Bio 2024; 24: 100907.

Zheng J, Fan R, Wu H, et al. Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation. Nature Communications 2019; 10(1): 1604.

Gao S, Zheng H, Xu S, et al. Novel Natural Carrier-Free Self-Assembled Nanoparticles for Treatment of Ulcerative Colitis by Balancing Immune Microenvironment and Intestinal Barrier. Advanced Healthcare Materials 2023; 12(31): e2301826.

Yu X, Zhang Z, Yu J, et al. Self-assembly of a ibuprofen-peptide conjugate to suppress ocular inflammation. Nanomedicine: Nanotechnology, Biology, and Medicine 2018; 14(1): 185-193.

Luo R, Liu J, Cheng Q, et al. Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis. Science Advances 2024; 10(26): eado6798.

An R, Li P, Li H, et al. Multifunctionalized PEG derivatives-based inverse opal photonic microspheres with a broad thermo operating window and pH responsiveness. Sensors and Actuators B: Chemical 2025; 445: 138620.

Lončarević Vrabec A, Bazina I, Vlahović L, et al. Chitosan/calcium phosphate microspheres as smart, multi-functional delivery systems for targeted bone cancer treatment. Colloids and Surfaces B: Biointerfaces 2026; 257: 115163.

Yuan Z, Das S, Lazenby RA, et al. Repetitive drug releases from light-activatable micron-sized liposomes. Colloids and Surfaces. A, Physicochemical and Engineering Aspects 2021; 625: 126778.

Polak R, Lim RM, Beppu MM, et al. Liposome‐Loaded Cell Backpacks. Advanced Healthcare Materials 2015; 4(18): 2832-2841.

Garello F, Stefania R, Aime S, et al. Successful entrapping of liposomes in glucan particles: an innovative micron-sized carrier to deliver water-soluble molecules. Molecular Pharmaceutics 2014; 11(10): 3760-3765.

Pan H, Zhang C, Jiang W, et al. Living Self‐Assembly of Monodisperse Micron‐Sized Polymer Vesicles. Angewandte Chemie International Edition 2024; 63(27): e202404589.

Dini L, Tacconi S, Carata E, et al. Microvesicles and exosomes in metabolic diseases and inflammation. Cytokine & Growth Factor Reviews 2020; 51: 27-39.

Pan H, Zhang C, Jiang W, et al. Living Self-Assembly of Monodisperse Micron-Sized Polymer Vesicles. Angewandte Chemie (International Ed. in English) 2024; 63(27): e202404589.

Wei L, Wang X, Wu L G. How micron-sized exocrine vesicles release content: A comparison with sub-micron endocrine vesicles. The Journal of Cell Biology 2023; 222(11): e202310047.

Yu Z, Xu Q, Dong C, et al. Self-Assembling Peptide Nanofibrous Hydrogel as a Versatile Drug Delivery Platform. Current Pharmaceutical Design 2015; 21(29): 4342-4354.

Huang C, Dong L, Zhao B, et al. Anti‐inflammatory hydrogel dressings and skin wound healing. Clinical and Translational Medicine 2022; 12(11): e1094.

Wu Y, Zhou Z, Zhang M, et al. Hollow manganese dioxide-chitosan hydrogel for the treatment of atopic dermatitis through inflammation-suppression and ROS scavenging. Journal of Nanobiotechnology 2023; 21(1): 432.

Shah S, Dhawan V, Holm R, et al. Liposomes: Advancements and innovation in the manufacturing process. Advanced Drug Delivery Reviews 2020; 154-155: 102-122.

Rocha S, Luísa Corvo M, Freitas M, et al. Liposomal quercetin: A promising strategy to combat hepatic insulin resistance and inflammation in type 2 diabetes mellitus. International Journal of Pharmaceutics 2024; 661: 124441.

Ryu JS, Park HS, Kim MJ, et al. Liposomal fusion of plant-based extracellular vesicles to enhance skin anti-inflammation. Journal of Industrial and Engineering Chemistry 2025; 144: 443-453.

Zhang Y, Zhou T, Wang K. Corneal Mucin-Targeting Liposome Nanoplatforms Enable Effective Treatment of Dry Eye Diseases by Integrated Regulation of Ferroptosis and Inflammation. Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 2025; 12(3): e2411172.

Tsay YF, Blatt MR, Gilliham M, et al. Integrating membrane transport, signaling, and physiology. Plant Physiology 2022; 188(2): 921-923.

Castanheira FVS, Kubes P. Neutrophils and NETs in modulating acute and chronic inflammation. Blood 2019; 133(20): 2178-2185.

Zhao D, Ravikumar V, Leach TJ, et al. Inflammation-induced epigenetic imprinting regulates intestinal stem cells. Cell Stem Cell 2024; 31(10): 1447-1464.e6.

Esim O, Adatepe S, Aksoy OA, et al. Targeted hepatic delivery of ezetimibe via red blood cell-coated nanoparticles for the treatment of non-alcoholic fatty liver disease through inflammation modulation. International Journal of Pharmaceutics 2025; 685: 126241.

Console L, Scalise M, Indiveri C. Exosomes in inflammation and role as biomarkers. Clinica Chimica Acta International Journal of Clinical Chemistry 2019; 488: 165-171.

Chan BD, Wong WY, Lee MML, et al. Exosomes in Inflammation and Inflammatory Disease. Proteomics 2019; 19(8): e1800149.

Li H, Feng Y, Zheng X, et al. M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. Journal of Controlled Release: Official Journal of the Controlled Release Society 2022; 341: 16-30.

Yan L, Cao Y, Hou L, et al. Ginger exosome-like nanoparticle-derived miRNA therapeutics: A strategic inhibitor of intestinal inflammation. Journal of Advanced Research 2025; 69: 1-15.

Liu F, Meng F, Yang Z, et al. Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters 2024; 35(9): 109335.

Cai Y, Zhou H, Zhu Y, et al. Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Research 2020; 30(7): 574-589.

Shi J, Li J. Neutrophil-targeted engineered prodrug nanoparticles for anti-inflammation. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2020; 34(8): 9828-9831.

Liu H, Ji M, Xiao P, et al. Glucocorticoids-based prodrug design: Current strategies and research progress. Asian Journal of Pharmaceutical Sciences 2024; 19(3): 100922.

Yu H, Gao R, Liu Y, et al. Stimulus-Responsive Hydrogels as Drug Delivery Systems for Inflammation Targeted Therapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11(1): e2306152.

Ma Z, Wu J, Sun M, et al. Disulfur-bridged polyethyleneglycol/DOX nanoparticles for the encapsulation of photosensitive drugs: a case of computational simulations on the redox-responsive chemo-photodynamic drug delivery system. RSC Advances 2021; 11(60): 37988-37994.

Haley RM, von Recum HA. Localized and targeted delivery of NSAIDs for treatment of inflammation: A review. Experimental Biology and Medicine (Maywood, N.J.) 2019; 244(6): 433-444.

Montiel Schneider M G, Martín M J, Otarola J, et al. Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives. Pharmaceutics 2022; 14(1): 204.

Sun J, Ju F, Jin J, et al. M2 Macrophage Membrane-Mediated Biomimetic-Nanoparticle Carrying COX-siRNA Targeted Delivery for Prevention of Tendon Adhesions by Inhibiting Inflammation. Small (Weinheim an Der Bergstrasse, Germany) 2023; 19(33): e2300326.

Adepu S, Ramakrishna S. Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules (Basel, Switzerland) 2021; 26(19): 5905.

Senanayake D, Yapa P, Dabare S, et al. Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery. RSC Advances 2025; 15(32): 25910-25928.

Zainal-Abidin MH, Hayyan M, Ngoh GC, et al. Emerging frontiers of deep eutectic solvents in drug discovery and drug delivery systems. Journal of Controlled Release 2019; 316: 168-195.

Qu J, Zhao X, Ma PX, et al. Injectable antibacterial conductive hydrogels with dual response to an electric field and pH for localized “smart” drug release. Acta Biomaterialia 2018; 72: 55-69.

Adepu S, Ramakrishna S. Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules (Basel, Switzerland) 2021; 26(19): 5905.

Feng X, Xie Q, Xu H, et al. Yeast Microcapsule Mediated Natural Products Delivery for Treating Ulcerative Colitis through Anti-Inflammatory and Regulation of Macrophage Polarization. ACS Applied Materials & Interfaces 2022; 14(27): 31085-31098.

Zainal-Abidin MH, Hayyan M, Ngoh GC, et al. Emerging frontiers of deep eutectic solvents in drug discovery and drug delivery systems. Journal of Controlled Release: Official Journal of the Controlled Release Society 2019; 316: 168-195.

Morozova OV, Vasil'eva IS, Shumakovich GP, et al. Deep Eutectic Solvents for Biotechnology Applications. Biochemistry (Mosc) 2023; 88(Suppl 1):S150-S175.

Ariga K, Nakanishi T, Michinobu T. Immobilization of biomaterials to nano-assembled films (self-assembled monolayers, Langmuir-Blodgett films, and layer-by-layer assemblies) and their related functions. Journal of Nanoscience and Nanotechnology 2006; 6(8): 2278-2301.

Cui W, Li J, Decher G. Self-Assembled Smart Nanocarriers for Targeted Drug Delivery. Advanced Materials (Deerfield Beach, Fla.) 2016; 28(6): 1302-1311.

Krasitskaya VV, Kudryavtsev AN, Yaroslavtsev RN, et al. Starch-Coated Magnetic Iron Oxide Nanoparticles for Affinity Purification of Recombinant Proteins. International Journal of Molecular Sciences 2022; 23(10): 5410.

Reyes-Ortega F, Delgado ÁV, Iglesias GR. Modulation of the Magnetic Hyperthermia Response Using Different Superparamagnetic Iron Oxide Nanoparticle Morphologies. Nanomaterials (Basel, Switzerland) 2021; 11(3): 627.

Dias AMM, Courteau A, Bellaye PS, et al. Superparamagnetic Iron Oxide Nanoparticles for Immunotherapy of Cancers through Macrophages and Magnetic Hyperthermia. Pharmaceutics 2022; 14(11): 2388.

Tombácz E, Turcu R, Socoliuc V, et al. Magnetic iron oxide nanoparticles: Recent trends in design and synthesis of magnetoresponsive nanosystems. Biochemical and Biophysical Research Communications 2015; 468(3): 442-453.

Montiel Schneider MG, Martín MJ, Otarola J, et al. Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives. Pharmaceutics 2022; 14(1): 204.

Demming A. Nanotechnological selection. Nanotechnology 2013; 24(2): 020201.

Wu J, Zhu Y, You L, et al. Polymer Electrochromism Driven by Metabolic Activity Facilitates Rapid and Facile Bacterial Detection and Susceptibility Evaluation. Advanced Functional Materials 2020; 30(49): 2005192.

Zhao J, Wu S, Qin J, et al. Electrical-Charge-Mediated Cancer Cell Targeting via Protein Corona-Decorated Superparamagnetic Nanoparticles in a Simulated Physiological Environment. ACS Applied Materials & Interfaces 2018; 10(49): 41986-41998.

Bendix MB, Houston A, Forde PF, et al. Electrochemotherapy and immune interactions; A boost to the system?. European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2022; 48(9): 1895-1900.

Qu J, Zhao X, Ma PX, et al. Injectable antibacterial conductive hydrogels with dual response to an electric field and pH for localized “smart” drug release. Acta Biomaterialia 2018; 72: 55-69.

Li L, Liang X, He T, et al. Multifunctional light-activatable nanocomplex conducting temperate-heat photothermal therapy to avert excessive inflammation and trigger augmented immunotherapy. Biomaterials 2022; 290: 121815.

Li H, Wang H, Xu Z, et al. Thermal-Responsive and Fire-Resistant Materials for High-Safety Lithium-Ion Batteries. Small (Weinheim an Der Bergstrasse, Germany) 2021; 17(43): e2103679.

Krawczyk K, Xue S, Buchmann P, et al. Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice. Science (New York, N.Y.) 2020; 368(6494): 993-1001.

Zhao S, Sun J, Qin Z, et al. Janus-Structural AIE Nanofiber with White Light Emission and Stimuli-Response. Small (Weinheim an Der Bergstrasse, Germany) 2022; 18(24): e2201117.

Su W, Liu P. Research Progress in the Treatment of Inflammatory Diseases. Journal of Xi'an University(Natural Science Edition) 2021; 24(01): 69-79.

Jiang Y, Trotsyuk AA, Niu S, et al. Wireless, closed-loop, smart bandage with integrated sensors and stimulators for advanced wound care and accelerated healing. Nature Biotechnology 2023; 41(5): 652-662.

Li Y, Zhang L, Song Z, et al. Intelligent temperature-pH dual responsive nanocellulose hydrogels and the application of drug release towards 5-fluorouracil. International Journal of Biological Macromolecules 2022; 223(Pt A): 11-16.

Sattari M, Fathi M, Daei M, et al. Thermoresponsive graphene oxide - starch micro/nanohydrogel composite as biocompatible drug delivery system. BioImpacts: BI 2017; 7(3): 167-175.

Sotoudehbagha P, Flores AC, Hartmann T, et al. Bone-targeted ultrasound-responsive nanobubbles for siRNA delivery to treat osteoporosis in mice. Biomaterials Advances 2025; 166: 214078.

Li Q, Wang YX, Chen Y. Unraveling Ultrasonic Stress Response of Nanovesicles by the Mechanochromism of Self-Assembled Polydiacetylene. ACS Macro Letters 2022; 11(1): 103-109.

Santos HM, Kouvonen P, Capelo JL, et al. On-target ultrasonic digestion of proteins. Proteomics 2013; 13(9): 1423-1427.

Yang S, Qu C, Yuan X, et al. Biomimetic hydrogel microsphere encapsulated superoxide dismutase enzymes alleviate postoperative peritoneal adhesion by modulating oxidative stress-inflammation cycles via Piezo1 mechanosensitive channels. Chemical Engineering Journal 2025; 524: 169275.

Qiao Q, Wang J, Li B, et al. Ti3C2Tx MXene nanosheet-based drug delivery/cascaded enzyme system for combination cancer therapy and anti-inflammation. Applied Materials Today 2024; 38: 102215.

Li X, Xie S, Yang Y, et al. Vitamin E inhibits inflammation and improves immune response of mud crabs (Scylla paramamosain) by activating an antioxidant enzyme system and apoptosis mechanism. Animal Nutrition 2025; 22: 19-35.

Ding H, Tan P, Fu S, et al. Preparation and application of pH-responsive drug delivery systems. Journal of Controlled Release: Official Journal of the Controlled Release Society 2022; 348: 206-238.

Wang Y, Zhang Y, Yang Z, et al. Mesoporous silica-based nanocarriers with dual response to pH and ROS for enhanced anti-inflammation therapy of 5-demethylnobiletin against psoriasis-like lesions. International Journal of Pharmaceutics 2023; 645: 123373.

Sun Y, Zhang Z, Zheng CQ, et al. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: A review. World Journal of Gastroenterology 2021; 27(22): 2963-2978.

Sharkey KA, Mawe GM. The enteric nervous system. Physiological Reviews 2023; 103(2): 1487-1564.

Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet (London, England) 2017; 390(10114): 2769-2778.

Yu YR, Rodriguez JR. Clinical presentation of Crohn’s, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Seminars in Pediatric Surgery 2017; 26(6): 349-355.

An J, Liu Y, Wang Y, et al. The Role of Intestinal Mucosal Barrier in Autoimmune Disease: A Potential Target. Frontiers in Immunology 2022; 13: 871713.

Yang C, Merlin D. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. International Journal of Nanomedicine 2019; 14: 8875-8889.

Wang V, Boguniewicz J, Boguniewicz M, et al. The infectious complications of atopic dermatitis. Annals of Allergy, Asthma & Immunology: Official Publication of the American College of Allergy, Asthma, & Immunology 2021; 126(1): 3-12.

Sugumaran D, Yong ACH, Stanslas J. Advances in psoriasis research: From pathogenesis to therapeutics. Life Sciences 2024; 355: 122991.

Scheinman PL, Vocanson M, Thyssen JP, et al. Contact dermatitis. Nature Reviews. Disease Primers 2021; 7(1): 38.

Meledathu S, Naidu MP, Brunner PM. Update on atopic dermatitis. The Journal of Allergy and Clinical Immunology 2025; 155(4): 1124-1132.

Shirley SN, Watson AE, Yusuf N. Pathogenesis of Inflammation in Skin Disease: From Molecular Mechanisms to Pathology. International Journal of Molecular Sciences 2024; 25(18): 10152.

Bruschi ML, Borghi-Pangoni FB, Junqueira MV, et al. Environmentally Responsive Systems for Drug Delivery. Recent Patents on Drug Delivery & Formulation 2017; 11(2): 89-100.

Labaki WW, Rosenberg SR. Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine 2020; 173(3): ITC17-ITC32.

Lange P, Ahmed E, Lahmar ZM, et al. Natural history and mechanisms of COPD. Respirology (Carlton, Vic.) 2021; 26(4): 298-321.

Xu J, Zeng Q, Li S, et al. Inflammation mechanism and research progress of COPD. Frontiers in Immunology 2024; 15: 1404615.

Uwagboe I, Adcock IM, Lo Bello F, et al. New drugs under development for COPD. Minerva Medica 2022; 113(3): 471-496.

Deng Z, Zheng Y, Cai P, et al. The Role of B and T Lymphocyte Attenuator in Respiratory System Diseases. Frontiers in Immunology 2021; 12: 635623.

Berillo D, Yeskendir A, Zharkinbekov Z, et al. Peptide-Based Drug Delivery Systems. Medicina (Kaunas, Lithuania) 2021; 57(11): 1209.

Cheung CK, Alexander S, Reich HN, et al. The pathogenesis of IgA nephropathy and implications for treatment. Nature Reviews Nephrology; 2025, 21(1): 9-23.

Lamba P, Nam KH, Contractor J, et al. Nephritic Syndrome. Primary Care 2020; 47(4): 615-629.

Han Y, Zhang HX. Research progress in treatment of chronic viral hepatitis B with traditional Chinese medicine. Shanxi Journal of Traditional Chinese Medicine 2024; 40(11): 64-66.

Yu JJ, Liu ZF, Li J. Research progress on health-related quality of life in patients with chronic viral hepatitis C. Chinese Journal of AIDS & STD 2023; 29(02): 230-233.

Olivas I, Rodríguez-Tajes S, Londoño MC. Autoimmune hepatitis: Challenges and novelties. Medicina Clinica 2022; 159(6): 289-298.

Ogawa Y, Takeuchi T, Tsubota K. Autoimmune Epithelitis and Chronic Inflammation in Sjögren’s Syndrome-Related Dry Eye Disease. International Journal of Molecular Sciences 2021; 22(21): 11820.

Das T, Joseph J, Simunovic MP, et al. Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives. Progress in Retinal and Eye Research 2023; 97: 101218.

Bihaniya H, Rudraprasad D, Joseph J. Pathobiology of Fungal Endophthalmitis: A Major Review. ACS Infectious Diseases 2024; 10(9): 3126-3137.

Zagora SL, Cornish EE, Symes RJ, et al. Inflammatory eye and rheumatic disease. International Journal of Rheumatic Diseases 2019; 22(12): 2091-2095.

Huang J, Fu X, Chen X, et al. Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. Frontiers in Immunology 2021; 12: 686155.

Poddubnyy D, Jadon DR, Van den Bosch F. Axial involvement in psoriatic arthritis: An update for rheumatologists. Seminars in Arthritis and Rheumatism 2021; 51(4): 880-887.

Mueller AL, Payandeh Z, Mohammadkhani N, et al. Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells 2021; 10(11): 3017.

Mathew AJ, Ravindran V. Infections and arthritis. Best Practice & Research. Clinical Rheumatology 2014; 28(6): 935-959.

Janakiraman K, Krishnaswami V, Rajendran V, et al. Novel nano therapeutic materials for the effective treatment of rheumatoid arthritis-recent insights. Materials Today. Communications 2018; 17: 200-213.

Kong P, Cui ZY, Huang XF, et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduction and Targeted Therapy 2022, 7(1): 131.

Chapman FA, Maguire JJ, Newby DE, et al. Targeting the apelin system for the treatment of cardiovascular diseases. Cardiovascular Research 2023; 119(17): 2683-2696.

Dougherty S, Okello E, Mwangi J, et al. Rheumatic Heart Disease: JACC Focus Seminar 2/4. Journal of the American College of Cardiology 2023; 81(1): 81-94.

Waszczykowska A, Żyro D, Ochocki J. Clinical Application and Efficacy of Silver Drug in Ophthalmology: A Literature Review and New Formulation of EYE Drops with Drug Silver (I) Complex of Metronidazole with Improved Dosage Form. Biomedicines 2021; 9(2): 210.

Downloads

Published

2026-03-31

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Issue

Section

Review

Similar Articles

41-50 of 102

You may also start an advanced similarity search for this article.